Literature DB >> 17970075

Quantification of CD10 mRNA in colorectal cancer and relationship between mRNA expression and liver metastasis.

Shin Fujita1, Seiichiro Yamamoto, Takayuki Akasu, Yoshihiro Moriya, Hirokazu Taniguchi, Tadakazu Shimoda.   

Abstract

UNLABELLED: CD10 mRNA expression in colorectal cancer and its relationship with cancer progression and prognosis were investigated. PATIENTS AND METHODS: CD10 mRNA was quantified in 167 colorectal cancer and matched normal tissue samples using real-time polymerase chain reaction (RT-PCR). The tumor to normal tissue (TIN) CD10 mRNA ratio was compared with clinicopathological factors and prognosis.
RESULTS: CD10 mRNA was overexpressed in 138 of the 167 tumors in comparison with the matched normal tissues. TIN was higher in colon, pN1/pN2, stage III and IV, and well- or moderately-differentiated adenocarcinoma than in rectum, pNO, stage I and II, and poorly-differentiated or mucinous adenocarcinoma, respectively. However, these differences were not significant. TIN was not associated with prognosis.
CONCLUSION: CD10 mRNA showed significantly higher expression in tumor tissues than in matched normal tissues. Although CD10 mRNA was associated with invasion depth, lymph node status and TNM stage, it was not associated with prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17970075

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  The role of neprilysin in regulating the hair cycle.

Authors:  Naoko Morisaki; Atsushi Ohuchi; Shigeru Moriwaki
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 2.  Cell surface markers in colorectal cancer prognosis.

Authors:  Larissa Belov; Jerry Zhou; Richard I Christopherson
Journal:  Int J Mol Sci       Date:  2010-12-28       Impact factor: 5.923

3.  Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma.

Authors:  Marwa T Hussien; Eatemad Helmy; Tarek M Elsaba; Azza Elkady; Hani Alrefai; Helal F Hetta
Journal:  Asian Pac J Cancer Prev       Date:  2020-06-01

Review 4.  Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?

Authors:  Magdalena Mizerska-Dudka; Martyna Kandefer-Szerszeń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-09-06       Impact factor: 4.291

5.  Neutral endopeptidase (NEP) is differentially involved in biological activities and cell signaling of colon cancer cell lines derived from various stages of tumor development.

Authors:  Magdalena Mizerska-Kowalska; Agnieszka Bojarska-Junak; Joanna Jakubowicz-Gil; Martyna Kandefer-Szerszeń
Journal:  Tumour Biol       Date:  2016-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.